Research ties insulin to higher mortality risk in diabetes

01/14/2013 | FoodConsumer.org

Type 2 diabetes patients who were on insulin treatment had an 89% higher risk of all-cause mortality and 116% higher risk of cancer-related death than nonusers, a study revealed. However, researchers noted diabetes patients on insulin did not have a higher overall risk of cancer. The findings appear in PLoS One.

View Full Article in:

FoodConsumer.org

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA